•  1971 Incorporation of Bharat Serums and Vaccines Limited
     1972 Establishes Blood Bank
     1972 Exports Polyclonal Sera
     1978 Commissioning of the Thane Plant
     1980 Launch of Indigenously developed Plasma fractions
     1982 Import Substitution Awards from the Indian Government for Anti D Blood Grouping Sera Strips for detection of Diabetes
     1982 Receives R&D recognition by Department of Scientific and Industrial Research, Government Of India
     1983 Launch of Pseudoglob- India’s first Pseudomonas globulin
     1996 Sets up three independent focused R&D divisions
     1998 Launch of Rhoclone – World’s First monoclonal Anti D
     1999 Filing of the first Product Patent Application
     2000 Equity Investment from reputed Indian Institutional Investors
     2001 Commissioning of the Animal Farm at Khoni, near Mumbai
     2003 Commissioning of the injectable Manufacturing Facility at Amberanth, near Mumbai
     2003 Incorporation of BSV Bio Inc. USA
     2005 Formation of Zydus BSV Pharma, a 50:50 Joint Venture  with Zydus Cadila
     2007 Incorporation of BSV Bio GMbh, Germany
     2007 Equity Investment from reputed Indian Institutional Investors
     2008 Equity Investment from reputed Global Institutional Investors
     2008 Launch of Foligraf- India's first recombinant FSH Biosimilar Product
    2010 EU approval of the German Subsidiary, BSV Bio
    2011 Commissioning of the Biotech facility at Ambernath, near Mumbai
    2012 Launch of U-Tryp- India's first Ulinastatin formulation for Sepsis
    2012 Frost and Sullivan award for the Fastest Growing Biotech Company